Chronic Urticaria — My Urticaria Worsened After I Had Covid-19

Reading time: 11 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Chronic Urticaria — My Urticaria Worsened After I Had Covid-19

Clinical Summary and Overview

When symptoms or doubts arise involving Chronic UrticariaDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "Chronic Urticaria — My Urticaria Worsened After I Had Covid-19", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Chronic Urticaria — My Urticaria Worsened After I Had Covid-19

Chronic Urticaria and Worsening Symptoms After Covid-19

One of the major challenges faced by patients living with chronic urticaria is the exacerbation of symptoms after coronavirus infection. Reports from people who required hospitalization and experienced a significant worsening of their condition—to the point where high doses of antihistamines ceased to be effective—illustrate a complex clinical reality studied by allergy and immunology specialists.

The relationship between SARS-CoV-2 infection and the worsening of skin manifestations is frequently associated with the concepts of viral persistence and so-called "long COVID." Like other respiratory viruses, the coronavirus possesses mechanisms that can prolong its latency in the body or generate a prolonged chronic inflammatory response. This persistence keeps the immune system in a constant state of alert, which favors the dysregulation of cells fundamental to allergic processes.

The pathophysiological mechanism behind this phenomenon involves the direct activation of specific receptors present on the mast cell membrane, known as Toll-like receptors (Toll-like receptorsWhen these receptors are stimulated by viral components or by inflammatory mediators resulting from infection, mast cell degranulation occurs—a process in which these cells release histamine and other vasoactive substances into the body. This event triggers the so-called mast cell activation syndrome, resulting in the appearance or intensification of the reddish and itchy lesions characteristic of chronic urticaria.

In cases of refractory post-COVID urticaria, medical management requires a comprehensive and individualized approach. Treatment should not focus solely on blocking skin symptoms with antihistamines, but also on investigating and supporting the immune system so that the body can restore balance and adequately control the persistent inflammatory process.

It is important to emphasize that this content is strictly educational and informative in nature, and in no way replaces an in-person medical consultation, accurate diagnosis, and the development of an individualized treatment plan by a specialist physician within the scope of the Brazil Without Allergies Project or its care network.

Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema

In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.

💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management

Mast Cell Activation, Histamine, and the Bradykinin Pathway

Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.

Therapeutic Escalation without Overuse of Corticosteroids

Identifying aggravating cofactors—especially the use of nonsteroidal anti-inflammatory drugs (NSAIDs), acute stress, and physical stimuli—is part of the specialized consultation. Through the allergy test well-indicated and requiring continuous monitoring aimed at stabilizing mast cells and, in patients with atopic respiratory comorbidities, at allergy vaccineComplete control of symptoms is achieved while preserving overall health.

Vaccine Mechanisms, Excipients, and Assessment of Immune Competence

In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.

Clinical Safety Criteria and Warning Signs in Allergology

Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions linked to Chronic Urticaria profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Chronic Urticaria This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: